PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Clinical trial NCT01037556 · UNKNOWN

Trial details

NCT number: NCT01037556
Sponsor: Proacta, Incorporated
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Lymphocytic Leukemia

Start date: 2010-01-01
Primary completion: 2012-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.